World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
12553
World Ranking
11979
National Ranking
922

Overview

Paul D. Smith is affiliated with AstraZeneca in the United Kingdom and focuses primarily on Environmental Science. Their research spans several interconnected subfields, including Atmospheric Science, Global and Planetary Change, Ecology, Organic Chemistry, and Pulmonary and Respiratory Medicine.

The scientist's work covers a diverse range of topics, with notable concentration in Atmospheric and Environmental Gas Dynamics, Atmospheric chemistry and aerosols, Metal-Organic Frameworks: Synthesis and Applications, Atmospheric Ozone and Climate, Customer Service Quality and Loyalty, Service and Product Innovation, and Digital Marketing and Social Media.

Paul D. Smith has contributed to multiple peer-reviewed publications. Some of the recent papers include:

  • "Evaluation and optimization of ICOS atmosphere station data as part of the labeling process," 2021, published in Atmospheric Measurement Techniques
  • "Teach well, learn better - Customer involvement and new product performance in B2B markets: The role of desorptive and absorptive capacity," 2022, published in Industrial Marketing Management
  • "Megacity and local contributions to regional air pollution: an aircraft case study over London," 2020, published in Atmospheric Chemistry and Physics
  • "Diversity of movement patterns of Longnose Gar tracked in coastal waters of western Lake Ontario," 2023, published in Environmental Biology of Fishes
  • "Fragmentation in Collisions of Snow with Graupel/Hail: New Formulation from Field Observations," 2024, published in Journal of the Atmospheric Sciences

Their frequent collaborators include Claudio Mendicute-Fierro, Mark E. Light, Camille Yver Kwok, Carole Philippon, and P. Bergamaschi. These collaborations suggest active engagement across multiple research groups and disciplines.

Paul D. Smith's work has appeared often in prominent scientific journals and venues. Key publication venues include Cancer Research, Atmospheric Measurement Techniques, Industrial Marketing Management, Environmental Biology of Fishes, and Atmospheric Chemistry and Physics. Cancer Research stands out as a recurring journal for their contributions.

Best Publications

  • DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis

    Diane Crighton;Simon Wilkinson;Jim O'Prey;Nelofer Syed

  • Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

    Pasi A Jänne;Alice T Shaw;José Rodrigues Pereira;Gaëlle Jeannin

  • Gene Expression Profiling of Alveolar Rhabdomyosarcoma with cDNA Microarrays

    Javed Khan;Richard Simon;Michael Bittner;Yidong Chen

  • AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models

    Barry R. Davies;Armelle Logie;Jennifer S. McKay;Paul Martin

  • MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road.

    Christopher J. Caunt;Matthew J. Sale;Paul D. Smith;Simon J. Cook

  • Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial

    Pasi A. Jänne;Michel M. van den Heuvel;Fabrice Barlesi;Manuel Cobo

  • Activity of the Monocarboxylate Transporter 1 inhibitor AZD3965 in Small Cell Lung Cancer

    Radosław Polański;Cassandra L Hodgkinson;Alberto Fusi;Daisuke Nonaka

  • iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

    Daniele Bergamaschi;Yardena Samuels;Yardena Samuels;Yardena Samuels;Alexandra Sullivan;Marketa Zvelebil

  • Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

    Catherine A. Eberlein;Daniel Stetson;Aleksandra A. Markovets;Katherine J. Al-Kadhimi

  • The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer.

    Udai Banerji;D. Ross Camidge;Henk M. W. Verheul;Roshan Agarwal

  • Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma Cells

    Y.N. Vashisht Gopal;Wanleng Deng;Scott E. Woodman;Kakajan Komurov

  • Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)

    Jonathan R. Dry;Sandra Pavey;Sandra Pavey;Christine A. Pratilas;Chris Harbron

  • Challenges and Opportunities in Cancer Drug Resistance.

    Richard A Ward;Stephen Fawell;Nicolas Floc'h;Vikki Flemington

  • Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.

    E Anderton;J Yee;P Smith;T Crook

  • Amplification of the Driving Oncogene, KRAS or BRAF, Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells

    Annette S. Little;Kathryn Balmanno;Matthew J. Sale;Scott Newman

  • p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

    Tim Crook;Louise A Brooks;Susan Crossland;P Osin

  • Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots.

    Nicole Y. Morgan;Sean English;Wei Chen;Victor Chernomordik

  • The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP

    Fiamma Mantovani;Francesca Tocco;Javier Girardini;Paul Smith

  • Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non–Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models

    Jingchuan Zhang;Lin Zhang;Xinying Su;Ming Li

  • Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.

    Kostas Paschos;Paul Smith;Emma Anderton;Jaap M. Middeldorp

Frequent Co-Authors

Harvey I. Pass
Harvey I. Pass New York University
Thomas F. DeLaney
Thomas F. DeLaney Harvard University
Pasi A. Jänne
Pasi A. Jänne Harvard University
Simon J. Cook
Simon J. Cook Babraham Institute
Martin O. Leach
Martin O. Leach Royal Marsden NHS Foundation Trust
Eileen M. Lafer
Eileen M. Lafer The University of Texas Health Science Center at San Antonio
Martin B. Leon
Martin B. Leon Columbia University Medical Center
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Roy S. Herbst
Roy S. Herbst Yale University
Simon T. Barry
Simon T. Barry AstraZeneca (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens up a wide range of diverse career and educational opportunities. Many students leverage their science background to pursue specialized health and life science roles. For those interested in nutrition, dietitian masters programs can prepare graduates for rewarding careers as registered dietitians or nutrition specialists.

If you’re seeking entry into the healthcare field, there are flexible online medical assistant programs with financial aid designed to make training accessible and affordable, even for those balancing work or family.

Medical assistants can further advance their careers with a medical assistant to lpn bridge program online, offering a pathway toward higher qualifications and expanded responsibilities in patient care.

For students who want to deepen their science foundation or transition into lab research, an online biology degree provides a flexible, fast-track option for earning credentials and advancing in the field. Each of these pathways supports a dynamic science career in today’s evolving healthcare and research landscape.

Best Scientists Citing Paul D. Smith

Trending Scientists

Recently Published Articles